BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25900952)

  • 1. Current advances related to Clostridium difficile infection.
    Kim YG; Jang BI
    Indian J Med Res; 2015 Feb; 141(2):172-4. PubMed ID: 25900952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series.
    Bamba S; Nishida A; Imaeda H; Inatomi O; Sasaki M; Sugimoto M; Andoh A
    J Microbiol Immunol Infect; 2019 Aug; 52(4):663-666. PubMed ID: 29158082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
    Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
    Mizusawa M; Doron S; Gorbach S
    Drugs Aging; 2015 Aug; 32(8):639-47. PubMed ID: 26233437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
    Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK
    Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection: review.
    Czepiel J; Dróżdż M; Pituch H; Kuijper EJ; Perucki W; Mielimonka A; Goldman S; Wultańska D; Garlicki A; Biesiada G
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1211-1221. PubMed ID: 30945014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of adult Clostridium difficile digestive contaminations: a literature review.
    Mathias F; Curti C; Montana M; Bornet C; Vanelle P
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):209-231. PubMed ID: 30498879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring ways to improve CDI outcomes.
    Galpérine T; Guery B;
    Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
    Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
    Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection.
    Varier RU; Biltaji E; Smith KJ; Roberts MS; Jensen MK; LaFleur J; Nelson RE
    Clin Microbiol Infect; 2014 Dec; 20(12):1343-51. PubMed ID: 25366338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile: controversies and approaches to management.
    Bauer MP; van Dissel JT; Kuijper EJ
    Curr Opin Infect Dis; 2009 Dec; 22(6):517-24. PubMed ID: 19738464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of
    Oksi J; Anttila VJ; Mattila E
    Ann Med; 2020; 52(1-2):12-20. PubMed ID: 31801387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.